AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
CARDIOVASCULAR-DISEASE AND MORTALITY IN ESRD
Authors: FOLEY RN PARFREY PS
Citation: Rn. Foley et Ps. Parfrey, CARDIOVASCULAR-DISEASE AND MORTALITY IN ESRD, JN. Journal of nephrology, 11(5), 1998, pp. 239-245
MODE OF DIALYSIS THERAPY AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM ODEA R MURRAY DC BARRE PE
Citation: Rn. Foley et al., MODE OF DIALYSIS THERAPY AND MORTALITY IN END-STAGE RENAL-DISEASE, Journal of the American Society of Nephrology, 9(2), 1998, pp. 267-276
CARDIAC DISEASE IN THE DIABETIC DIALYSIS PATIENT
Authors: FOLEY RN PARFREY PS
Citation: Rn. Foley et Ps. Parfrey, CARDIAC DISEASE IN THE DIABETIC DIALYSIS PATIENT, Nephrology, dialysis, transplantation, 13(5), 1998, pp. 1112-1113
CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE
Authors: FOLEY RN PARFREY PS SARNAK MJ
Citation: Rn. Foley et al., CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE, American journal of kidney diseases, 32(5), 1998, pp. 112-119
SCREENING AND TREATMENT FOR CARDIOVASCULAR-DISEASE IN PATIENTS WITH CHRONIC RENAL-DISEASE
Authors: MURPHY SW FOLEY RN PARFREY PS
Citation: Sw. Murphy et al., SCREENING AND TREATMENT FOR CARDIOVASCULAR-DISEASE IN PATIENTS WITH CHRONIC RENAL-DISEASE, American journal of kidney diseases, 32(5), 1998, pp. 184-199
CONTROLLING THE EPIDEMIC OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE - WHAT DO WE KNOW - WHAT DO WE NEED TO LEARN - WHERE DO WE GO FROM HERE
Authors: LEVEY AS BETO JA CORONADO BE EKNOYAN G FOLEY RN KASISKE BL KLAG MJ MAILLOUX LU MANSKE CL MEYER KB PARFREY PS PFEFFER MA WENGER NK WILSON PWF WRIGHT JT
Citation: As. Levey et al., CONTROLLING THE EPIDEMIC OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE - WHAT DO WE KNOW - WHAT DO WE NEED TO LEARN - WHERE DO WE GO FROM HERE, American journal of kidney diseases, 32(5), 1998, pp. 853-906
LONG-TERM EVOLUTION OF CARDIOMYOPATHY IN DIALYSIS PATIENTS
Authors: FOLEY RN PARFREY PS KENT GM HARNETT JD MURRAY DC BARRE PE
Citation: Rn. Foley et al., LONG-TERM EVOLUTION OF CARDIOMYOPATHY IN DIALYSIS PATIENTS, Kidney international, 54(5), 1998, pp. 1720-1725
MORTALITY IN ESRD - THE RESCUE EFFECT OF SWITCHING FROM PD TO HEMODIALYSIS
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., MORTALITY IN ESRD - THE RESCUE EFFECT OF SWITCHING FROM PD TO HEMODIALYSIS, Journal of the American Society of Nephrology, 8, 1997, pp. 1007-1007
EARLY AND LATE MORTALITY IN ESRD - HAZARDS OF THE COX MODEL
Authors: FOLEY RN PARFREY PS KENT GM
Citation: Rn. Foley et al., EARLY AND LATE MORTALITY IN ESRD - HAZARDS OF THE COX MODEL, Journal of the American Society of Nephrology, 8, 1997, pp. 1303-1303
COMMENTARY - CARDIOMYOPATHY OF ANEMIA AND THE POTENTIAL OF ERYTHROPOIETIN
Authors: FOLEY RN PARFREY PS
Citation: Rn. Foley et Ps. Parfrey, COMMENTARY - CARDIOMYOPATHY OF ANEMIA AND THE POTENTIAL OF ERYTHROPOIETIN, Peritoneal dialysis international, 17(2), 1997, pp. 117-118
RISK-FACTORS FOR CARDIAC DYSFUNCTION IN DIALYSIS PATIENTS - IMPLICATIONS FOR PATIENT-CARE
Authors: PARFREY PS FOLEY RN
Citation: Ps. Parfrey et Rn. Foley, RISK-FACTORS FOR CARDIAC DYSFUNCTION IN DIALYSIS PATIENTS - IMPLICATIONS FOR PATIENT-CARE, Seminars in dialysis, 10(3), 1997, pp. 137-141
CARDIAC DISEASE IN DIABETIC END-STAGE RENAL-DISEASE
Authors: FOLEY RN CULLETON BF PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., CARDIAC DISEASE IN DIABETIC END-STAGE RENAL-DISEASE, Diabetologia, 40(11), 1997, pp. 1307-1312
CARDIAC DISEASE IN DIABETIC-PATIENTS WITH ESRD
Authors: CULLETON BF FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Bf. Culleton et al., CARDIAC DISEASE IN DIABETIC-PATIENTS WITH ESRD, Journal of the American Society of Nephrology, 7(9), 1996, pp. 977-977
MODE OF DIALYSIS, CARDIAC MORBIDITY AND MORTALITY IN ESRD
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., MODE OF DIALYSIS, CARDIAC MORBIDITY AND MORTALITY IN ESRD, Journal of the American Society of Nephrology, 7(9), 1996, pp. 993-993
HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE, Journal of the American Society of Nephrology, 7(5), 1996, pp. 728-736
OUTCOME AND RISK-FACTORS FOR LEFT-VENTRICULAR DISORDERS IN CHRONIC UREMIA
Authors: PARFREY PS FOLEY RN HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Ps. Parfrey et al., OUTCOME AND RISK-FACTORS FOR LEFT-VENTRICULAR DISORDERS IN CHRONIC UREMIA, Nephrology, dialysis, transplantation, 11(7), 1996, pp. 1277-1285
LEFT-VENTRICULAR DISORDERS DETECTED BY M-MODE ECHOCARDIOGRAPHY IN CHRONIC UREMIA
Authors: PARFREY PS COLLINGWOOD P FOLEY RN BAHRLE A
Citation: Ps. Parfrey et al., LEFT-VENTRICULAR DISORDERS DETECTED BY M-MODE ECHOCARDIOGRAPHY IN CHRONIC UREMIA, Nephrology, dialysis, transplantation, 11(7), 1996, pp. 1328-1331
THE IMPACT OF ANEMIA ON CARDIOMYOPATHY, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., THE IMPACT OF ANEMIA ON CARDIOMYOPATHY, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE, American journal of kidney diseases, 28(1), 1996, pp. 53-61
ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA
Authors: PARFREY PS FOLEY RN
Citation: Ps. Parfrey et Rn. Foley, ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA, Blood purification, 14(4), 1996, pp. 321-326
HYPOCALCEMIA, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM HU LQ ODEA R MURRAY DC BARRE PE
Citation: Rn. Foley et al., HYPOCALCEMIA, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE, American journal of nephrology, 16(5), 1996, pp. 386-393
IMPACT OF HYPERTENSION ON CARDIOMYOPATHY, MORBIDITY AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., IMPACT OF HYPERTENSION ON CARDIOMYOPATHY, MORBIDITY AND MORTALITY IN END-STAGE RENAL-DISEASE, Kidney international, 49(5), 1996, pp. 1379-1385
OUTCOME AND RISK-FACTORS OF ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA
Authors: PARFREY PS FOLEY RN HARNETT JD KENT GM MURRAY D BARRE PE
Citation: Ps. Parfrey et al., OUTCOME AND RISK-FACTORS OF ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA, Kidney international, 49(5), 1996, pp. 1428-1434
HYPOALBUMINEMIA - A MAJOR RISK FACTOR FOR CARDIAC DISEASE IN ESRD
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., HYPOALBUMINEMIA - A MAJOR RISK FACTOR FOR CARDIAC DISEASE IN ESRD, Journal of the American Society of Nephrology, 6(3), 1995, pp. 529-529
HYPERTENSION, CARDIOMYOPATHY, CARDIAC MORBIDITY AND MORTALITY IN ESRD
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., HYPERTENSION, CARDIOMYOPATHY, CARDIAC MORBIDITY AND MORTALITY IN ESRD, Journal of the American Society of Nephrology, 6(3), 1995, pp. 529-529
THE PROGNOSTIC IMPORTANCE OF LEFT-VENTRICULAR GEOMETRY IN UREMIC CARDIOMYOPATHY
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., THE PROGNOSTIC IMPORTANCE OF LEFT-VENTRICULAR GEOMETRY IN UREMIC CARDIOMYOPATHY, Journal of the American Society of Nephrology, 5(12), 1995, pp. 2024-2031
Risultati: 1-25 | 26-38